BB Biotech AG 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:48 pm Sale | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | BB Biotech AG | 0 0.000% | -141,125 (Position Closed) | Filing |
| 2021-02-12 4:17 pm Purchase | 2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | BB Biotech AG | 141,125 6.400% | 26,361 (+22.97%) | Filing |
| 2020-02-14 2:35 pm Unchanged | 2019-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | BB Biotech AG | 114,764 6.900% | 0 (Unchanged) | Filing |